Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean s adenosyl l methionine disulfide tosilate?
Displaying drugs 6226 - 6250 of 6672 in total

ENB-003

ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.
Investigational

Dalpiciclib

Investigational

GT-AS

GT-AS recombinant adeno-associated virus serotype 9 vector containing the transgene UBE3A encoding for ubiquitin protein ligase E3A/E6-AP.
Investigational

Ergidina

Ergidina is a recombinant human minibody against complement component C5 fused with RGD-motif.
Investigational

Cevidoplenib

Investigational

Benzylsulfonic acid

Experimental

Daglutril

Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure.
Investigational

Archexin

Investigational

Hemoglobin crosfumaril

Hemoglobin in which the alpha-subunit are cross-linked intramolecularly.
Experimental

CypCaps

Investigational

Zemirciclib

Investigational

Phenylpyruvic acid

Experimental

Guadecitabine

Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.
Investigational

R906289

R906289 is under investigation in clinical trial NCT05308264 (Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)).
Investigational

5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide

Experimental

1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate

Experimental

(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid

Experimental

N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide

Experimental

(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL

Experimental

4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline

Experimental

Autologous Non-Hematopoietic Peripheral Blood Stem Cells

Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.
Investigational

2-Naphthalenesulfonic acid

Experimental

Iopofosine I-124

Investigational

BMX-001 free base

Investigational

Vemircopan

Investigational
Displaying drugs 6226 - 6250 of 6672 in total